Search - tctmd.com

Displaying 921 - 940 of 989

Sort: Relevancy | Date

News Daily News

Rapid Bedside Genotyping May Help Guide Antiplatelet Strategy After PCI

Caitlin E. Cox

March 30, 2012

News Conference News ACC 2012

CPORT-E: PCI Outcomes Similar Regardless of On-Site Cardiac Surgery

March 25, 2012

News Conference News ACC 2012

Prasugrel Effective in Stable Patients With Poor Response to Clopidogrel

Jason Kahn

March 24, 2012

News Conference News ACC 2012

New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding

L.A. McKeown

March 24, 2012

News Daily News

COURAGE Substudy: Treat the Components, Not the Syndrome

March 06, 2012

News Daily News

CMR Outperforms SPECT for CAD Diagnosis in ‘Real-World’ Assessment

March 06, 2012

News Daily News

Subestudio COURAGE: Debe Tratarse cada Elemento, No el Síndrome en su Conjunto

March 06, 2012

News Daily News

Statins Reduce Late Restenosis After SES Implantation

Jason Kahn

March 05, 2012

News Daily News

Meta-Analysis Questions Appropriateness of PCI in Stable CAD

L.A. McKeown

March 05, 2012

News Daily News

Las Estatinas Reducen la Re-estenosis Tardía tras el Implante de un SLS

Jason Kahn

March 05, 2012

Presentation

Initial Coronary Stent Implantation with Medical Therapy vs. Medical Therapy Alone for Stable CAD

Presenter: Kathleen Stergiopoulos

February 26, 2012

News Daily News

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

L.A. McKeown

February 20, 2012

News Daily News

CLI Patients on Statins Show Improved Outcomes After Endovascular Treatment

Caitlin E. Cox

January 26, 2012

News Daily News

Meta-analysis: Data Do Not Support Genotyping for Clopidogrel Response

January 03, 2012

News Daily News

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

L.A. McKeown

December 08, 2011

News Daily News

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

December 04, 2011

News Conference News

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

L.A. McKeown

November 28, 2011

News Conference News

Higher Dosing Improves Clopidogrel Response in Carriers of Variant Genes

November 16, 2011

News Conference News

PRISM Individualized Informed Consent Improves PCI Choice, Experience

November 14, 2011

News Conference News

RAPID GENE: Validation of Point-of-Care Genetic Testing

November 09, 2011

Advertisement

Rapid Bedside Genotyping May Help Guide Antiplatelet Strategy After PCI

CPORT-E: PCI Outcomes Similar Regardless of On-Site Cardiac Surgery

Prasugrel Effective in Stable Patients With Poor Response to Clopidogrel

New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding

COURAGE Substudy: Treat the Components, Not the Syndrome

CMR Outperforms SPECT for CAD Diagnosis in ‘Real-World’ Assessment

Subestudio COURAGE: Debe Tratarse cada Elemento, No el Síndrome en su Conjunto

Statins Reduce Late Restenosis After SES Implantation

Meta-Analysis Questions Appropriateness of PCI in Stable CAD

Las Estatinas Reducen la Re-estenosis Tardía tras el Implante de un SLS

Initial Coronary Stent Implantation with Medical Therapy vs. Medical Therapy Alone for Stable CAD

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

CLI Patients on Statins Show Improved Outcomes After Endovascular Treatment

Meta-analysis: Data Do Not Support Genotyping for Clopidogrel Response

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year

Higher Dosing Improves Clopidogrel Response in Carriers of Variant Genes

PRISM Individualized Informed Consent Improves PCI Choice, Experience

RAPID GENE: Validation of Point-of-Care Genetic Testing

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content